Ralph Nader is a complete fucking tool. (Now put down the rocks.)
NEW YORK, April 27 (AScribe Newswire) -- Narcolepsy Network Inc., announced to its members today that Abbott Laboratories will cease production of Cylert, a medication used by an estimated 10,000 Americans afflicted with the sleep disorders of narcolepsy and idiopathic hypersomnia. In an untreated state, both of these disorders are characterized by excessive sleepiness and sleep attacks during the day. At the same time, Public Citizen's Health Research Group, on behalf of individuals with ADHD, has petitioned the FDA to ban Cylert and its generic equivalent, Pemoline, due to risks associated with this medication.
In a statement today, Sharon Smith, President of Narcolepsy Network, said, "Even with treatment, narcolepsy limits patients in every aspect of their lives. A ban on Pemoline will have a tremendously negative impact on those narcolepsy patients who cannot tolerate other agents. Tolerance levels for risk associated with a medication are tied to the existence of alternatives and the consequences foregoing treatment. Without a medication to relieve excessive daytime sleepiness, these patients will no longer be able to function well enough to continue their present daily activities. No life event is as devastating and far-reaching as the loss of one's ability to function. A ban on Pemoline will force individuals to resort to disability. They and their family members will suffer the economic consequences of a significantly reduced income and loss of medical and retirement benefits. Others will no longer be able to achieve sufficient wakefulness to accomplish the ordinary tasks essential to independent living and will become burdens to their families, the Social Security, Medicare and Medicaid Systems and to society in general. The ADHD population has many alternative medications from which to choose."
Not to mention....
November 8, 2005—Cylert, a central nervous system stimulant that was approved by the FDA for the treatment of attention deficit hyperactivity disorder (A DH D), has also been used to treat fatigue in MS. The FDA has now determined that the risk of liver toxicity from Cylert and generic pemoline products outweighs the benefits of this drug. In May 2005, Abbott chose to stop sales and marketing of Cylert in the U.S. All generic companies have also agreed to stop sales and marketing of this product (pemoline tablets and chewable tablets).
But you don't have to take my word for it. Mrs. Hayden is boiling over with rage, and honestly I think she presents a better case than I ever could....
If Ralph Nader is run over by a beer truck and killed, if a very large meteorite falls on the offices of Public Citizen and vaporizes the lot of them, I won’t feel sorry. Not the least little bit.
See? I just don't think I can top that.